Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis

Central European Journal of Public Health

Volumn 13, Issue 1, 2005, Pages 20-23

  Beran, J ^a   Dedek P ^a   Stepanova V ^a   Splino M ^b   Pozler, O ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

Anti HAV seroconversion; Anti HBs seroprotection; Autoimmune hepatitis; Combined vaccine; Vaccination

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS A; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMUNOGENICITY; MALE; RISK BENEFIT ANALYSIS; SEROCONVERSION; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; PROSPECTIVE STUDIES; VACCINES, COMBINED;

EID: 17144404554     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Czaja AJ: Autoimmune hepatitis - evolving concepts and treatment strategies. Dig Dis Sci, 1995; 40:435-456.
2. Krawitt EL: Autoimmune hepatitis. N Eng J Med, 1996; 334:897-903.
3. Manns MP: Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol, 1997; 12:256-271.
4. Meyerzum Büschenfelde KH, Lohse AW, Manns M, et al: Autoimmunity and liver disease. Hepatology, 1990; 12:354-363.
5. Trivedi P, Mowat AP: Chronic hepatitis. In: Suchy FJ. Liver disease in children. St. Louis: Mosby-Year Book; 1994;510-522.
6. Boberg KM, Aadland E, Jahnsen J et al: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol, 1998; 33:99-103.
7. Anon. http://www.niddk.nih.gov/health/digest/pubs/autoimmune/auto-hep.htm
8. Wirth S, Koletzko S: Autoimmunhepatitis im Kindesalter. Monatsschr Kinderheilkd, 1994; 142:908-916.
9. Czaja AJ: Diagnosis and therapy of autoimmune liver disease. Med Clin N Amer, 1996; 80:973-994.
10. Czaja AJ: Autoimmune hepatitis - evolving concepts and treatment strategies. Dig Dis Sci, 1995; 40:435-456.
11. Huppertz HI, Trcichel U, Gassel AM, et al: Autoimmune hepatitis following hepatitis A virus infection. J Hepatol, 1995; 23:204-208.
12. Manns MP, Obermayer-Straub P: Viral induction of autoimmunity: mechanisms and examples in hepatology. J Viral Hepatol, 1997; 4(Suppl. 2):42-47.
13. Keefe E, Iwarson S, McMahon BJ et al: Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology, 1998; 27 (3): 881-886.
14. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE: Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis, 1995; 171(Suppl 1):S44-49.
15. Safary A, André F: Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine, 2000; 18:57-67.